GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) will be announcing its earnings results before the market opens on Tuesday, April 30th. Analysts expect the company to announce earnings of $0.90 per share for the quarter. GE HealthCare Technologies has set its FY 2024 guidance at 4.200-4.350 EPS and its FY24 guidance at $4.20-$4.35 EPS.Investors interested in listening to the company’s conference call can do so using this link.
GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last released its quarterly earnings data on Tuesday, February 6th. The company reported $1.18 EPS for the quarter, topping analysts’ consensus estimates of $1.07 by $0.11. GE HealthCare Technologies had a net margin of 8.02% and a return on equity of 25.58%. The firm had revenue of $5.20 billion during the quarter, compared to analysts’ expectations of $5.09 billion. During the same period in the previous year, the business posted $1.31 earnings per share. The company’s revenue for the quarter was up 5.3% compared to the same quarter last year. On average, analysts expect GE HealthCare Technologies to post $4 EPS for the current fiscal year and $5 EPS for the next fiscal year.
GE HealthCare Technologies Trading Up 0.3 %
GEHC stock opened at $86.24 on Monday. The company has a debt-to-equity ratio of 1.18, a current ratio of 1.05 and a quick ratio of 0.83. The company has a fifty day moving average price of $88.92 and a two-hundred day moving average price of $78.59. GE HealthCare Technologies has a one year low of $62.35 and a one year high of $94.50. The stock has a market cap of $39.35 billion, a price-to-earnings ratio of 28.56, a price-to-earnings-growth ratio of 3.00 and a beta of 0.94.
GE HealthCare Technologies Dividend Announcement
Wall Street Analysts Forecast Growth
A number of equities research analysts have recently issued reports on the stock. Citigroup boosted their target price on shares of GE HealthCare Technologies from $88.00 to $103.00 and gave the company a “buy” rating in a research report on Wednesday, April 3rd. UBS Group raised shares of GE HealthCare Technologies from a “sell” rating to a “neutral” rating and boosted their target price for the company from $66.00 to $88.00 in a research report on Monday, February 12th. Argus boosted their target price on shares of GE HealthCare Technologies from $80.00 to $110.00 and gave the company a “buy” rating in a research report on Monday, April 1st. Morgan Stanley boosted their target price on shares of GE HealthCare Technologies from $74.00 to $86.00 and gave the company an “equal weight” rating in a research report on Monday, February 12th. Finally, Mizuho boosted their target price on shares of GE HealthCare Technologies from $96.00 to $110.00 and gave the company a “buy” rating in a research report on Thursday, April 11th. Four research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat.com, GE HealthCare Technologies currently has a consensus rating of “Moderate Buy” and an average price target of $95.09.
Get Our Latest Research Report on GE HealthCare Technologies
GE HealthCare Technologies Company Profile
GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.
Read More
- Five stocks we like better than GE HealthCare Technologies
- How to Invest in Biotech Stocks
- Snap Crackles and Pops on Surprise Profit and Raised Guidance
- Trading Stocks: RSI and Why it’s Useful
- MarketBeat Week in Review – 4/22 – 4/26
- Using the MarketBeat Dividend Tax Calculator
- 3 Stocks Leading the U.S. Agriculture Comeback
Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.